Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
13 participants
OBSERVATIONAL
2011-11-30
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural History Study of Patients With Limb-Girdle Muscular Dystrophy 2I
NCT03842878
Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E
NCT03488784
Evaluation of Limb-Girdle Muscular Dystrophy
NCT00893334
Limb-Girdle Muscular Dystrophy Type 2I in Norway
NCT03930628
Long-Term Development of Muscular Dystrophy Outcome Assessments
NCT05989620
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LGMD
Patients with GENETICALLY CONFIRMED limb girdle muscular dystrophy
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* You must be at least 6 years of age or older (if under 18 you will need Parental consent)
* You must be able to travel to the study site
* You must be able to provide a DNA/Gene testing report that confirms a diagnosis of LGMD
Exclusion Criteria
* Your child is under age 6
* You or your child are not able to travel to the study site
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Muscular Dystrophy Association
OTHER
Wake Forest University Health Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ibrahim Binalsheikh, MD
Role: PRINCIPAL_INVESTIGATOR
Carolinas Medical Center - Pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Carolinas Medical Center - Pediatrics
Charlotte, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LGMD Nat Hx
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.